Header Logo

Connection

Natasha Durham to HIV Fusion Inhibitors

This is a "connection" page, showing publications Natasha Durham has written about HIV Fusion Inhibitors.
Connection Strength

0.249
  1. Esposito AM, Cheung P, Swartz TH, Li H, Tsibane T, Durham ND, Basler CF, Felsenfeld DP, Chen BK. A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry. Virology. 2016 Mar; 490:6-16.
    View in: PubMed
    Score: 0.131
  2. Swartz TH, Esposito AM, Durham ND, Hartmann BM, Chen BK. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection. J Virol. 2014 Oct; 88(19):11504-15.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.